Literature DB >> 15070099

3H dendrimer nanoparticle organ/tumor distribution.

Shraddha S Nigavekar1, Lok Yun Sung, Mikel Llanes, Areej El-Jawahri, Theodore S Lawrence, Christopher W Becker, Lajos Balogh, Mohamed K Khan.   

Abstract

PURPOSE: To determine the in vivo biodistribution for differently charged poly(amidoamine) (PAMAM) dendrimers in B16 melanoma and DU145 human prostate cancer mouse tumor model systems.
METHODS: Neutral (NSD) and positive surface charged (PSD) generation 5 (d = 5 nm) PAMAM dendrimers were synthesized by using 3H-labeled acetic anhydride and tested in vivo. Dendrimer derivatives were injected intravenously, and their biodistribution was determined via liquid scintillation counting of tritium in tissue and excretory samples. Mice were also monitored for acute toxicity.
RESULTS: Both PSD and NSD localized to major organs and tumor. Dendrimers cleared rapidly from blood, with deposition peaking at 1 h for most organs and stabilizing from 24 h to 7 days postinjection. Maximal excretion occurred via urine within 24 h postinjection. Neither dendrimer showed acute toxicity.
CONCLUSIONS: Changes in the net surface charge of polycationic PAMAMs modify their biodistribution. PSD deposition into tissues is higher than NSD, although the biodistribution trend is similar. Highest levels were found in lungs, liver, and kidney, followed by those in tumor, heart, pancreas, and spleen, while lowest levels were found in brain. These nanoparticles could have future utility as systemic biomedical delivery devices.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070099     DOI: 10.1023/B:PHAM.0000019302.26097.cc

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Encapsulation of guest molecules into a dendritic box.

Authors:  J F Jansen; E M de Brabander-van den Berg; E W Meijer
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

2.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.

Authors:  R Esfand; D A. Tomalia
Journal:  Drug Discov Today       Date:  2001-04-01       Impact factor: 7.851

3.  The use of PAMAM dendrimers in the efficient transfer of genetic material into cells.

Authors: 
Journal:  Pharm Sci Technol Today       Date:  2000-07

4.  Openings between defective endothelial cells explain tumor vessel leakiness.

Authors:  H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 5.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

6.  Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.

Authors:  A Bielinska; J F Kukowska-Latallo; J Johnson; D A Tomalia; J R Baker
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

7.  Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer.

Authors:  H Kobayashi; N Sato; S Kawamoto; T Saga; A Hiraga; T L Haque; T Ishimori; J Konishi; K Togashi; M W Brechbiel
Journal:  Bioconjug Chem       Date:  2001 Jan-Feb       Impact factor: 4.774

8.  Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect.

Authors:  P A Stewart; K Hayakawa; C L Farrell; R F Del Maestro
Journal:  J Neurosurg       Date:  1987-11       Impact factor: 5.115

Review 9.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers.

Authors:  D S Wilbur; P M Pathare; D K Hamlin; K R Buhler; R L Vessella
Journal:  Bioconjug Chem       Date:  1998 Nov-Dec       Impact factor: 4.774

View more
  30 in total

1.  Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition.

Authors:  Donald E Mager; Vidhi Mody; Chao Xu; Alan Forrest; Wojciech G Lesniak; Shraddha S Nigavekar; Muhammed T Kariapper; Leah Minc; Mohamed K Khan; Lajos P Balogh
Journal:  Pharm Res       Date:  2012-06-12       Impact factor: 4.200

Review 2.  Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.

Authors:  Wassana Wijagkanalan; Shigeru Kawakami; Mitsuru Hashida
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

3.  Developmental toxicity of low generation PAMAM dendrimers in zebrafish.

Authors:  Tisha C King Heiden; Emelyne Dengler; Weiyuan John Kao; Warren Heideman; Richard E Peterson
Journal:  Toxicol Appl Pharmacol       Date:  2007-07-31       Impact factor: 4.219

4.  Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model.

Authors:  Anjali Sharma; Joshua E Porterfield; Elizabeth Smith; Rishi Sharma; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2018-06-05       Impact factor: 9.776

Review 5.  Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?

Authors:  Peter Hoet; Barbara Legiest; Jorina Geys; Benoit Nemery
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation.

Authors:  Wojciech G Lesniak; Manoj K Mishra; Amar Jyoti; Bindu Balakrishnan; Fan Zhang; Elizabeth Nance; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Mol Pharm       Date:  2013-10-30       Impact factor: 4.939

Review 7.  A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules.

Authors:  Sheila M Barros; Susan K Whitaker; Pinakin Sukthankar; L Adriana Avila; Sushanth Gudlur; Matt Warner; Eduardo I C Beltrão; John M Tomich
Journal:  Arch Biochem Biophys       Date:  2016-02-27       Impact factor: 4.013

8.  Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.

Authors:  Ken L Chambliss; Qian Wu; Sarah Oltmann; Eddy S Konaniah; Michihisa Umetani; Kenneth S Korach; Gail D Thomas; Chieko Mineo; Ivan S Yuhanna; Sung Hoon Kim; Zeynep Madak-Erdogan; Adriana Maggi; Sean P Dineen; Christina L Roland; David Y Hui; Rolf A Brekken; John A Katzenellenbogen; Benita S Katzenellenbogen; Philip W Shaul
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

9.  Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis.

Authors:  Brett C Geiger; Sheryl Wang; Robert F Padera; Alan J Grodzinsky; Paula T Hammond
Journal:  Sci Transl Med       Date:  2018-11-28       Impact factor: 17.956

10.  Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes.

Authors:  Jiumei Chen; Jessica A Hessler; Krishna Putchakayala; Brian K Panama; Damian P Khan; Seungpyo Hong; Douglas G Mullen; Stassi C Dimaggio; Abhigyan Som; Gregory N Tew; Anatoli N Lopatin; James R Baker; Mark M Banaszak Holl; Bradford G Orr
Journal:  J Phys Chem B       Date:  2009-08-13       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.